COLL - Company ID 0001267565
The table below shows COLLEGIUM PHARMACEUTICAL, INC's income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $780.57M | $631.45M | $566.77M | $463.93M | $276.87M | $310.02M |
| Cost of revenue | $317.31M | $254.10M | $240.60M | $254.44M | $126.25M | $130.18M |
| Gross profit | $463.26M | $377.34M | $326.17M | $209.49M | $150.62M | $179.84M |
| R&D | - | $0.00 | $0.00 | $3.98M | $9.45M | $9.77M |
COLLEGIUM PHARMACEUTICAL, INC reported annual revenue of $780.57M for fiscal year 2025. That is up 23.6% from $631.45M in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $1.71M (FY 2016) to $780.57M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $284.80M |
| $210.36M |
| $159.21M |
| $172.19M |
| $118.96M |
| $113.83M |
| Operating income | $179.64M | $169.90M | $166.96M | $33.32M | $17.63M | $56.23M |
| Income tax | $29.75M | $29.38M | $27.58M | -$3.85M | -$74.89M | $830.00K |
| Net income | $63.00M | $69.00M | $48.00M | -$25.00M | $72.00M | $26.75M |
| EPS (diluted) | $1.73 | $1.86 | $1.29 | -$0.74 | $1.86 | $0.76 |